OBJECTIVE: To describe genetic analyses of the 2 most thoroughly studied, historically seminal multigenerational families with Alexander disease described prior to the identification of GFAP as the related gene, as well as 1 newly discovered family. DESIGN: Clinical histories were obtained and DNA was analyzed from blood, cheek epithelial cells, or fixed paraffin-embedded surgical samples. SUBJECTS: Affected and unaffected adult members of 3 families and affected children were included. MAIN OUTCOME MEASURES: Mutations in GFAP and behavior of mutant protein in cellular transfection assays. RESULTS: Family A contains 4 siblings in whom we found a novel p.Ser247Pro mutation that was paternally inherited. The phenotypes of these siblings include 1 unaffected adult, 1 individual with juvenile-onset disease, and 2 individuals with adult-onset disease. Family B spans 4 generations, including the first described patient with adult-onset disease originally reported in 1968. Analysis of members of the later generations revealed a novel p.Asp417Ala mutation. Family C contains 3 generations. We detected a novel p.Gln426Leu mutation that, to our knowledge, is the farthest C-terminal mutation known. CONCLUSIONS: These families display clear evidence of variable phenotypes but do not support recessive inheritance. While germline mosaicism cannot be excluded for 1 family (A), we propose that for genetic counseling purposes the risk of germline mosaicism should be described as less than 1%.
OBJECTIVE: To describe genetic analyses of the 2 most thoroughly studied, historically seminal multigenerational families with Alexander disease described prior to the identification of GFAP as the related gene, as well as 1 newly discovered family. DESIGN: Clinical histories were obtained and DNA was analyzed from blood, cheek epithelial cells, or fixed paraffin-embedded surgical samples. SUBJECTS: Affected and unaffected adult members of 3 families and affected children were included. MAIN OUTCOME MEASURES: Mutations in GFAP and behavior of mutant protein in cellular transfection assays. RESULTS: Family A contains 4 siblings in whom we found a novel p.Ser247Pro mutation that was paternally inherited. The phenotypes of these siblings include 1 unaffected adult, 1 individual with juvenile-onset disease, and 2 individuals with adult-onset disease. Family B spans 4 generations, including the first described patient with adult-onset disease originally reported in 1968. Analysis of members of the later generations revealed a novel p.Asp417Ala mutation. Family C contains 3 generations. We detected a novel p.Gln426Leu mutation that, to our knowledge, is the farthest C-terminal mutation known. CONCLUSIONS: These families display clear evidence of variable phenotypes but do not support recessive inheritance. While germline mosaicism cannot be excluded for 1 family (A), we propose that for genetic counseling purposes the risk of germline mosaicism should be described as less than 1%.
Authors: Erika Stumpf; Hélène Masson; Antoine Duquette; France Berthelet; Julia McNabb; Anne Lortie; Jacques Lesage; Jacques Montplaisir; Bernard Brais; Patrick Cossette Journal: Arch Neurol Date: 2003-09
Authors: Alexei Verkhratsky; Michael V Sofroniew; Albee Messing; Nihal C deLanerolle; David Rempe; José Julio Rodríguez; Maiken Nedergaard Journal: ASN Neuro Date: 2012-04-05 Impact factor: 4.146
Authors: Paige L Jany; Guillermo E Agosta; William S Benko; Jens C Eickhoff; Stephanie R Keller; Wolfgang Köehler; David Koeller; Soe Mar; Sakkubai Naidu; Jayne Marie Ness; Davide Pareyson; Deborah L Renaud; Ettore Salsano; Raphael Schiffmann; Julie Simon; Adeline Vanderver; Florian Eichler; Marjo S van der Knaap; Albee Messing Journal: eNeuro Date: 2015-10-01
Authors: Nicole J Boczek; Ashley N Sigafoos; Michael T Zimmermann; Rachel L Maus; Margot A Cousin; Patrick R Blackburn; Raul Urrutia; Karl J Clark; Marc C Patterson; Myra J Wick; Eric W Klee Journal: Clin Case Rep Date: 2016-08-15